Nano Cap New Millennium Growth Fund L P acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the fourth quarter, Holdings Channel reports. The fund acquired 10,000 shares of the exchange traded fund’s stock, valued at approximately $1,219,000.
A number of other hedge funds have also made changes to their positions in XBI. Legacy Wealth Managment LLC ID acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $32,000. Ballast Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $36,000. Creative Financial Designs Inc. ADV acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $39,000. Barnes Dennig Private Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $48,000. Finally, Navalign LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $48,000.
SPDR S&P Biotech ETF Stock Up 0.8%
Shares of SPDR S&P Biotech ETF stock opened at $132.78 on Friday. The stock has a market capitalization of $8.47 billion, a P/E ratio of 11.47 and a beta of 0.85. The company has a 50-day simple moving average of $129.72 and a 200 day simple moving average of $125.00. SPDR S&P Biotech ETF has a 12-month low of $78.00 and a 12-month high of $139.19.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
See Also
- Five stocks we like better than SPDR S&P Biotech ETF
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
